[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8570 Introduced in House (IH)]

<DOC>






118th CONGRESS
  2d Session
                                H. R. 8570

 To establish a pharmacy program to award grants for safe in-home drug 
   disposal and practical medication safety education, and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 24, 2024

  Mr. Hudson introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To establish a pharmacy program to award grants for safe in-home drug 
   disposal and practical medication safety education, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Safe In-Home Drug Disposal 
Initiative Act of 2024'' or the ``SIDDI Act of 2024''.

SEC. 2. SAFE IN-HOME DRUG DISPOSAL INITIATIVE.

    (a) In General.--Not later than 180 days after the date of 
enactment of this Act, the Secretary of Health and Human Services, 
acting through the Assistant Secretary for Mental Health and Substance 
Use, (in this section referred to as the ``Secretary'') shall establish 
a program to award grants to States to implement targeted State 
demonstration initiatives (in this section referred to as ``TSDIs''). 
Such TSDIs shall reimburse licensed pharmacies that choose to 
participate in the TSDI (in this section referred to as ``participating 
pharmacies'') for the provision to eligible patients, in coordination 
with the delivery of drug prescriptions, of in-home drug disposal 
systems and standard medication safety education.
    (b) Application.--To be eligible to receive a grant under this 
section, a State shall submit to the Secretary an application at such 
time, in such manner, and containing such information as the Secretary 
may require. Such an application shall--
            (1) identify the State agency that oversees pharmaceutical 
        care and will be responsible for administering a TSDI through a 
        grant under this section;
            (2) identify the single pharmacy benefit manager (commonly 
        known as a ``PBM'') that will be responsible for--
                    (A) adjudicating claims under the TSDI;
                    (B) reimbursing participating pharmacies; and
                    (C) facilitating the type of customization required 
                to successfully administer a custom, fully transparent 
                program, with pass-through claims adjudication services 
                benefitting patients, plans, and pharmacies;
            (3) outline the process by which participating pharmacies 
        will submit usual and customary costs related to the 
        reimbursement and remuneration of services, including detailed 
        reporting on--
                    (A) criteria of patient selection;
                    (B) initial activity; and
                    (C) patient engagement factors;
            (4) detail the process through which standard medication 
        safety education will be communicated by each participating 
        pharmacist or pharmacy technician at the point of dispensing, 
        allowing for unique needs and education to be tailored for 
        State-, county-, town-, and municipality-specific needs;
            (5) detail a plan to increase participation rates of 
        pharmacists and pharmacy technicians through a single 
        electronic pharmacy claim process;
            (6) state the remuneration amounts for the provision of 
        standard medication safety education, and the reimbursement 
        amounts for in-home drug disposal systems, which for each 
        eligible patient shall be assessed separately but processed 
        through a single electronic claim;
            (7) describe how the State will select pharmacies to be 
        served under the TSDI; and
            (8) include the number of eligible patients to be served 
        under the TSDI.
    (c) Number.--The Secretary shall award grants under this section to 
not more than 5 States.
    (d) Grant Period.--A grant awarded under this section shall be for 
a period of at least 3 years.
    (e) Accountability and Oversight.--As a condition of receiving a 
grant under this section, a State shall agree to submit to the 
Secretary, at such time and in such manner as the Secretary may 
reasonably require, a report on the TSDI of the State implemented 
through such grant. Such report shall--
            (1) list the number of pharmacy locations that are 
        reimbursed through the grant funds;
            (2) describe the activities undertaken by the State using 
        the grant amounts, outlining the in-home drug disposal 
        solutions distributed and the patient education delivered;
            (3) survey pharmacies to collect demographic information on 
        participating patients, medication types prescribed, and the 
        effective use of the in-home drug disposal systems; and
            (4) contain performance measures relating to the 
        effectiveness of the grant, including changes in the 
        participation rate of eligible patients and the engagement with 
        pharmacists.
    (f) Definitions.-- In this section:
            (1) Eligible patients.--The term ``eligible patients'' 
        means patients receiving an opioid prescription who are at risk 
        of experiencing an opioid-related overdose, including such 
        patients--
                    (A) with a first-time opioid prescription;
                    (B) with an acute opioid prescription prescribed 
                for a short-term illness or condition; or
                    (C) that have received a change in the opioid 
                dosage of an acute or chronic opioid prescription.
            (2) In-home drug disposal system.-- The term ``in-home drug 
        disposal system'' means a system of drug disposal--
                    (A) that changes the physical integrity of the 
                formulation of a drug;
                    (B) that renders the active ingredients of such 
                drug unusable for all practical purposes;
                    (C) that--
                            (i) is nontoxic and nonhazardous;
                            (ii) poses no threat to the consumer; and
                            (iii) reduces drug exposure to the 
                        environment; and
                    (D) that acts as a deterrent for misuse of drugs.
            (3) Standard medication safety education.--The term 
        ``standard medication safety education'' means medication 
        safety education--
                    (A) provided by a pharmacist or pharmacy technician 
                to eligible patients for a duration of not more than 5 
                minutes per patient; and
                    (B) that includes information relating to--
                            (i) proper medication storage;
                            (ii) risks associated with keeping unused 
                        medication in the home;
                            (iii) proper in-home disposal of unused 
                        medication; and
                            (iv) in the case of naloxone that is 
                        prescribed as an opioid medication, the proper 
                        use of such naloxone
            (4) State.--The term ``State'' means each of the several 
        States, the District of Columbia, and any territory of the 
        United States.
    (g) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section $56,000,000 for the period of 
fiscal years 2025 through 2029.
                                 <all>